Vincenzo Russo, Andreina Carbone, Filiberto Fausto Mottola, Rosa Mocerino, Raffaele Verde, Emilio Attena, . . . Sergio Severino. (2020). Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients. Frontiers Media S.A..
Chicago Style (17th ed.) CitationVincenzo Russo, et al. Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients. Frontiers Media S.A., 2020.
MLA (9th ed.) CitationVincenzo Russo, et al. Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients. Frontiers Media S.A., 2020.